Provided by Tiger Trade Technology Pte. Ltd.

Benitec Biopharma

8.87
+0.12001.37%
Post-market: 8.880.0100+0.11%19:30 EDT
Volume:73.14K
Turnover:650.33K
Market Cap:309.41M
PE:-9.07
High:9.03
Open:8.72
Low:8.71
Close:8.75
52wk High:16.76
52wk Low:8.52
Shares:34.88M
Float Shares:18.45M
Volume Ratio:0.27
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9783
EPS(LYR):-0.9800
ROE:-33.21%
ROA:-22.67%
PB:1.75
PE(LYR):-9.05

Loading ...

Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2020

Major Issues Report

8-K - Current report
Oct 27, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 01, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 23, 2020

Major Issues Report

8-K - Current report
Sep 23, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 19, 2020

Major Issues Report

8-K/A [Amend] - Current report
Aug 18, 2020

Major Issues Report

8-K - Current report
Aug 14, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 05, 2020

Major Issues Report

8-K - Current report
Apr 15, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 03, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 31, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]